We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current APLM market cap is 28.74M. The company's latest EPS is USD -2.7745 and P/E is -0.12.
Quarter End | |
---|---|
USD ($) | |
Total Revenue | |
Operating Income | |
Net Income |
Year End December 30 2022 | 2022 |
---|---|
USD ($) | |
Total Revenue | 1.45M |
Operating Income | -233.6M |
Net Income | -240.81M |
Quarter End | |
---|---|
USD ($) | |
Total Assets | |
Total Liabilities | |
Total Equity |
Year End December 30 2022 | 2022 |
---|---|
USD ($) | |
Total Assets | 76.48M |
Total Liabilities | 524.6M |
Total Equity | -448.12M |
Market Cap | 28.74M |
Price to Earnings Ratio | -0.12 |
Price to Sales Ratio | 19.76 |
Price to Cash Ratio | 0.88 |
Price to Book Ratio | -0.06 |
Dividend Yield | - |
Shares Outstanding | 86.8M |
Average Volume (1 week) | 135.12k |
Average Volume (1 Month) | 190.46k |
52 Week Change | -92.99% |
52 Week High | 6.45 |
52 Week Low | 0.3116 |
Spread (Intraday) | 0.01 (2.62%) |
Company Name | Apollomics Inc |
Address |
989 e. hillsdale blvd foster city, california 94404 |
Website | https://www.apollomicsinc.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions